As January comes to an end, here’s a clear snapshot of where pharmaceutical track & trace in Egypt stands today.
Egypt officially announced in late 2025 the implementation of a national pharmaceutical track & trace system, covering:
=Serialization & Aggregation
=Imported products starting February2026
=Locally manufactured products starting August 2026
𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝟔𝟎𝟒 𝐝𝐞𝐟𝐢𝐧𝐞𝐝:
=Mandatory reporting events
=Responsibilities of each supply chain entity
=Clear compliance expectations
SAP has been selected as the technology provider for the national hub,
𝐈𝐦𝐩𝐨𝐫𝐭𝐞𝐝 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐫𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 (𝐩𝐡𝐚𝐬𝐞𝐝 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡)
According to informed sources quoted by Al-Mal Newspaper:
Imported products will not be registered all at once,Registration will be phased.
𝐏𝐡𝐚𝐬𝐞 𝟏
Starts second week of February
Runs for 3 months
No new imported SKUs added during this phase
𝐏𝐡𝐚𝐬𝐞 𝟐
Opens after Phase 1
Adds new imported products,copmanies
Also runs for 3 months
𝐏𝐢𝐥𝐨𝐭 𝐩𝐡𝐚𝐬𝐞
The pilot will be controlled and limited:
57 pharmacies owned by the Egyptian Company for Trading Pharmaceuticals
Distributors involved:
Egyptian Company for Trading Pharmaceuticals
Ibn Sina
Pharma Overseas
Scope includes:
A limited number of imported products
Narcotic medicines, dispensed exclusively through ambulance pharmacies
𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
4 billion packs sold in 2025 (vs. 3.5 billion in 2024)
Market value: USD 8.8 billion (vs. USD 6.2 billion)
Local manufacturing ~91%Represents 70% of sales value
Imports ~9% Represent 30% of sales value
𝐈𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞:
~180 local manufacturers
~1,600 warehouses
~80,000 pharmacies (not all active)
~12,000 registered products